Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Davidson

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|November 16, 2021
Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus NephritisAndrea Fava, Deepak A Rao, Chandra Mohan, et al.
The Journal of Experimental Medicine|November 9, 2017
Bim suppresses the development of SLE by limiting myeloid inflammatory responsesFuNien Tsai, Philip J Homan, Hemant Agrawal, et al.
The Journal of Pediatrics|June 28, 2025
Implementation Fidelity of a Smartphone Application for Population-Based General Movement Assessment: The Early Moves StudyCaroline F Alexander, Sarah E Hall, Alison Salt, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment responseRufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)|October 20, 2019
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritisCynthia Aranow, John Cush, Marcy B Bolster, et al.
BMJ Open|April 10, 2021
Early Moves: a protocol for a population-based prospective cohort study to establish general movements as an early biomarker of cognitive impairment in infantsCatherine Elliott, Caroline Alexander, Alison Salt, et al.
Blood|April 7, 2021
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registryDimitrios Giannis, Steven L Allen, James Tsang, et al.
Rheumatology (Oxford, England)|March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis NetworkPhilip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Care & Research|October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to TreatmentAndrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy|February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus NetworkPeter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Arthritis & Rheumatology (Hoboken, N.J.)|November 16, 2021
Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus NephritisAndrea Fava, Deepak A Rao, Chandra Mohan, et al.
The Journal of Experimental Medicine|November 9, 2017
Bim suppresses the development of SLE by limiting myeloid inflammatory responsesFuNien Tsai, Philip J Homan, Hemant Agrawal, et al.
The Journal of Pediatrics|June 28, 2025
Implementation Fidelity of a Smartphone Application for Population-Based General Movement Assessment: The Early Moves StudyCaroline F Alexander, Sarah E Hall, Alison Salt, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment responseRufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)|October 20, 2019
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritisCynthia Aranow, John Cush, Marcy B Bolster, et al.
BMJ Open|April 10, 2021
Early Moves: a protocol for a population-based prospective cohort study to establish general movements as an early biomarker of cognitive impairment in infantsCatherine Elliott, Caroline Alexander, Alison Salt, et al.
Blood|April 7, 2021
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registryDimitrios Giannis, Steven L Allen, James Tsang, et al.
Rheumatology (Oxford, England)|March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis NetworkPhilip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Care & Research|October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to TreatmentAndrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy|February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus NetworkPeter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Pageof 15